Compile Data Set for Download or QSAR
maximum 50k data
Found 45 Enz. Inhib. hit(s) with all data for entry = 9720
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483889(US10927106, Compound 4-93)
Affinity DataIC50:  40nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483905(US10927106, Compound PST-170)
Affinity DataIC50:  43.7nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483913(US10927106, Compound PST-155)
Affinity DataIC50:  51.8nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483894(US10927106, Compound 5-85)
Affinity DataIC50:  56nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483897(US10927106, Compound 1-31)
Affinity DataIC50:  65nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483926(US10927106, Compound PST-098)
Affinity DataIC50:  77.4nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483912(US10927106, Compound PST-156)
Affinity DataIC50:  93.8nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483895(US10927106, Compound 5-51)
Affinity DataIC50:  145nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483911(US10927106, Compound PST-157)
Affinity DataIC50:  150nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483896(US10927106, Compound 1-19)
Affinity DataIC50:  153nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483900(US10927106, Compound 1-17)
Affinity DataIC50:  162nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483916(US10927106, Compound PST-148)
Affinity DataIC50:  171nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483909(US10927106, Compound PST-162)
Affinity DataIC50:  175nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483902(US10927106, Compound PST-206)
Affinity DataIC50:  207nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483899(US10927106, Compound 1-27)
Affinity DataIC50:  208nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483929(US10927106, Compound PST-095)
Affinity DataIC50:  236nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483930(US10927106, Compound PST-087)
Affinity DataIC50:  247nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483890(US10927106, Compound 4-95)
Affinity DataIC50:  260nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483928(US10927106, Compound PST-096)
Affinity DataIC50:  273nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483891(US10927106, Compound 4-99)
Affinity DataIC50:  280nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483906(US10927106, Compound PST-169)
Affinity DataIC50:  281nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483933(US10927106, Compound PST-075)
Affinity DataIC50:  306nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483904(US10927106, Compound PST-173)
Affinity DataIC50:  330nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483931(US10927106, Compound PST-077)
Affinity DataIC50:  337nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483914(US10927106, Compound PST-154)
Affinity DataIC50:  350nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483920(US10927106, Compound PST-129 | US10927106, Compoun...)
Affinity DataIC50:  351nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483898(US10927106, Compound 1-29)
Affinity DataIC50:  375nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483923(US10927106, Compound PST-122)
Affinity DataIC50:  413nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483917(US10927106, Compound PST-147)
Affinity DataIC50:  487nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483927(US10927106, Compound PST-097)
Affinity DataIC50:  488nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483901(US10927106, Compound PST-288)
Affinity DataIC50:  491nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483924(US10927106, Compound PST-120)
Affinity DataIC50:  534nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483907(US10927106, Compound PST-164)
Affinity DataIC50:  593nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483918(US10927106, Compound PST-141)
Affinity DataIC50:  637nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483915(US10927106, Compound PST-151)
Affinity DataIC50:  644nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483903(US10927106, Compound PST-201)
Affinity DataIC50:  644nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483925(US10927106, Compound PST-110)
Affinity DataIC50:  658nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483919(US10927106, Compound PST-134)
Affinity DataIC50:  789nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483922(US10927106, Compound PST-128)
Affinity DataIC50:  808nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483932(US10927106, Compound PST-076)
Affinity DataIC50:  904nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483910(US10927106, Compound PST-158)
Affinity DataIC50:  922nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483893(US10927106, Compound 5-23)
Affinity DataIC50:  3.68E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483920(US10927106, Compound PST-129 | US10927106, Compoun...)
Affinity DataIC50:  3.86E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483908(US10927106, Compound PST-163)
Affinity DataIC50:  5.42E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Pharmasum Therapeutics

US Patent
LigandPNGBDBM483892(US10927106, Compound 5-25)
Affinity DataIC50:  5.64E+3nMAssay Description:The principal method utilized is a radioactive filter binding assay using 33P ATP This method is sensitive, accurate and provides a direct measure o...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent